Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214987) titled 'PDT For Induction Therapy For Head And Neck Cancer' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Massachusetts General Hospital
Condition:
Squamous Cell Carcinoma
Head and Neck Cancer Squamous Cell Carcinoma
Head and Neck Cancer
Intervention:
Drug: Toripalimab-tpzi
Drug: Cisplatin
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: March 9, 2026
Target Sample Size: 26
Countries of Recruitment:
United States
To know more, visit https://c...